PortfoliosLab logoPortfoliosLab logo
GERM vs. WBIY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GERM vs. WBIY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and WBI Power Factor High Dividend ETF (WBIY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*

WBIY

1D
0.69%
1M
2.63%
YTD
10.76%
6M
11.81%
1Y
27.44%
3Y*
17.19%
5Y*
9.29%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. WBIY - Yearly Performance Comparison


2026 (YTD)20252024
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%
WBIY
WBI Power Factor High Dividend ETF
10.76%13.00%0.20%

GERM vs. WBIY - Sectors Allocation Comparison


Sectors
GERM
WBIY

Healthcare

99.3%
6.2%

Financial Services

0.4%
18.7%

Basic Materials

-

1.9%

Communication Services

-

11.0%

Consumer Cyclical

-

13.1%

Consumer Defensive

-

16.4%

Energy

-

6.0%

Industrials

-

9.4%

Real Estate

-

1.1%

Technology

-

10.1%

Utilities

-

6.1%

Healthcare

GERM
99.3%
WBIY
6.2%

Financial Services

GERM
0.4%
WBIY
18.7%

Basic Materials

GERM

-

WBIY
1.9%

Communication Services

GERM

-

WBIY
11.0%

Consumer Cyclical

GERM

-

WBIY
13.1%

Consumer Defensive

GERM

-

WBIY
16.4%

Energy

GERM

-

WBIY
6.0%

Industrials

GERM

-

WBIY
9.4%

Real Estate

GERM

-

WBIY
1.1%

Technology

GERM

-

WBIY
10.1%

Utilities

GERM

-

WBIY
6.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GERM vs. WBIY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GERM

WBIY
WBIY Risk / Return Rank: 6262
Overall Rank
WBIY Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
WBIY Sortino Ratio Rank: 6262
Sortino Ratio Rank
WBIY Omega Ratio Rank: 5353
Omega Ratio Rank
WBIY Calmar Ratio Rank: 8181
Calmar Ratio Rank
WBIY Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. WBIY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and WBI Power Factor High Dividend ETF (WBIY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GERM vs. WBIY - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GERMWBIYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

Drawdowns

GERM vs. WBIY - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum WBIY drawdown of -48.71%. Use the drawdown chart below to compare losses from any high point for GERM and WBIY.


Loading charts...

Drawdown Indicators


GERMWBIYDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-48.71%

+48.71%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

-6.63%

+6.63%

Max Drawdown (3Y)

Largest decline over 3 years

-19.37%

Max Drawdown (5Y)

Largest decline over 5 years

-20.97%

Current Drawdown

Current decline from peak

0.00%

-1.15%

+1.15%

Average Drawdown

Average peak-to-trough decline

0.00%

-7.11%

+7.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

2.62%

-2.62%

Volatility

GERM vs. WBIY - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while WBI Power Factor High Dividend ETF (WBIY) has a volatility of 3.67%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than WBIY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GERMWBIYDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

3.67%

-3.67%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

8.92%

-8.92%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

15.07%

-15.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

18.51%

-18.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

22.65%

-22.65%

GERM vs. WBIY - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is lower than WBIY's 0.97% expense ratio.


Dividends

GERM vs. WBIY - Dividend Comparison

GERM has not paid dividends to shareholders, while WBIY's dividend yield for the trailing twelve months is around 4.38%.


PositionTTM2025202420232022202120202019201820172016
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WBIY
WBI Power Factor High Dividend ETF
4.38%4.73%4.57%4.87%4.40%3.94%5.10%4.54%3.25%5.84%0.01%

Frequently Asked Questions


WBIY has higher volatility (3.67%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs WBIY's -48.71%.

On 1-year performance, WBIY leads with 27.44% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, WBIY has performed better with a 27.44% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

GERM is cheaper with a 0.68% expense ratio, compared with 0.97% for WBIY.

WBIY has the higher dividend yield at 4.38%, compared with 0.00% for GERM.

GERM is categorized as Health & Biotech Equities, while WBIY is Mid Cap Value Equities. GERM tracks Prime Treatments, Testing and Advancements Index, while WBIY tracks Solactive Power Factor High Dividend Index. They also come from different issuers: Amplify and WBI. Their fees differ too: 0.68% for GERM and 0.97% for WBIY.

Portfolio Optimizer

Find the right allocation for GERM and WBIY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer